作者
S Anazi, S Maddirevula, E Faqeih, H Alsedairy, F Alzahrani, HE Shamseldin, N Patel, M Hashem, N Ibrahim, F Abdulwahab, N Ewida, HS Alsaif, W Alamoudi, A Kentab, FA Bashiri, M Alnaser, AH AlWadei, M Alfadhel, W Eyaid, A Hashem, A Al Asmari, MM Saleh, A AlSaman, KA Alhasan, M Alsughayir, M Al Shammari, A Mahmoud, ZN Al-Hassnan, M Al-Husain, R Osama Khalil, Abd El Meguid, A Masri, R Ali, T Ben-Omran, P El Fishway, A Hashish, A Ercan Sencicek, M State, AM Alazami, MA Salih, N Altassan, ST Arold, M Abouelhoda, SM Wakil, D Monies, R Shaheen, FS Alkuraya
发表日期
2017/4
期刊
Molecular psychiatry
卷号
22
期号
4
页码范围
615-624
出版商
Nature Publishing Group
简介
Intellectual disability (ID) is a measurable phenotypic consequence of genetic and environmental factors. In this study, we prospectively assessed the diagnostic yield of genomic tools (molecular karyotyping, multi-gene panel and exome sequencing) in a cohort of 337 ID subjects as a first-tier test and compared it with a standard clinical evaluation performed in parallel. Standard clinical evaluation suggested a diagnosis in 16% of cases (54/337) but only 70% of these (38/54) were subsequently confirmed. On the other hand, the genomic approach revealed a likely diagnosis in 58%(n= 196). These included copy number variants in 14%(n= 54, 15% are novel), and point mutations revealed by multi-gene panel and exome sequencing in the remaining 43%(1% were found to have Fragile-X). The identified point mutations were mostly recessive (n= 117, 81%), consistent with the high consanguinity of the study cohort …
引用总数
20162017201820192020202120222023202451431432636282719
学术搜索中的文章